Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis.
Watanabe G, Takai Y, Nagane Y, Kubota T, Yasuda M, Akamine H, Onishi Y, Uzawa A, Kawaguchi N, Masuda M, Konno S, Amino I, Minami N, Kimura T, Samukawa M, Sugimoto T, Suzuki Y, Takahashi MP, Suzuki S, Murai H, Aoki M, Utsugisawa K.
Watanabe G, et al. Among authors: sugimoto t.
Front Immunol. 2024 Dec 23;15:1502721. doi: 10.3389/fimmu.2024.1502721. eCollection 2024.
Front Immunol. 2024.
PMID: 39763650
Free PMC article.